Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Gibson Christopher
Over the trailing 90 days, Gibson Christopher (Director at RECURSION PHARMACEUTICALS, INC.) sold $472K of stock across 2 companies, per 12 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 12 transactions · CIK 1856369
- Net activity
- −$472K ($0 bought · $472K sold)
By Company (Trailing 90 Days)
Transactions (12)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-05 | RXRX | Sell | 40.0K | $145K | Open market or private sale |
| 2026-06-05 | RXRX | Buy | 40.0K | $0 | Conversion of derivative security |
| 2026-06-05 | RXRX | Sell | 40.0K | $0 | Conversion of derivative security |
| 2026-06-03 | PACB | Buy | 74.5K | $0 | Grant, award or other acquisition |
| 2026-05-22 | RXRX | Sell | 40.0K | $123K | Open market or private sale |
| 2026-05-22 | RXRX | Sell | 40.0K | $0 | Conversion of derivative security |
| 2026-05-22 | RXRX | Buy | 40.0K | $0 | Conversion of derivative security |
| 2026-05-15 | RXRX | Sell | 22.8K | $69K | Payment of exercise price or tax liability by delivering securities |
| 2026-05-07 | RXRX | Sell | 60.0K | $0 | Conversion of derivative security |
| 2026-05-07 | RXRX | Buy | 60.0K | $0 | Conversion of derivative security |
| 2026-05-07 | RXRX | Sell | 40.0K | $135K | Open market or private sale |
| 2026-05-07 | RXRX | Sell | 20.0K | $0 | Gift (bona fide) |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Gibson's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.